Kim, Chang Woo
Kim, Hyunjin
Kim, Hyoung Rae
Kye, Bong-Hyeon
Kim, Hyung Jin
Min, Byung Soh
Oh, Tae Jeong
An, Sungwhan
Lee, Suk-Hwan
Clinical trials referenced in this document:
Documents that mention this clinical trial
Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial
https://doi.org/10.1186/s12876-021-01759-9
Funding for this research was provided by:
Genomictree, Inc.
Article History
Received: 2 November 2020
Accepted: 9 April 2021
First Online: 15 April 2021
Declarations
:
: The authors will follow the guidelines set forth in the Declaration of Helsinki to protect the patients. The trial will be performed according to the ICH-GCP guidelines. The institutional review board of the principal investigator (SH Lee) approved the trial (KHNMC 2019-10-019) at Kyung Hee University Hospital, Gangdong. To participate, all study subjects will understand and agree to the aims and process of the trial, possible results, and risks. Written informed consent must be provided in a language that participants can understand and be explained by an investigator. If participants cannot read the informed consent form, an investigator must read it to them in the presence of a witness. Even if a participant has signed the informed consent form, an investigator must stop any procedure that the participant refuses to proceed with. A copy of the signed informed consent form will be provided to the participant, while the original copy will be retained by the investigator for safekeeping.
: Not applicable.
: The authors declare that they have no competing interests. However, EarlyTectâ„¢-Colon Cancer tests will be provided by Genomictree, Daejeon, Korea.